Tandem Diabetes Care, Inc.
TNDM
$14.36
$0.362.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.86% | -17,392.19% | 103.25% | 24.54% | 27.86% |
| Total Depreciation and Amortization | 1.30% | 1.55% | 0.81% | 2.51% | 1.61% |
| Total Amortization of Deferred Charges | -7.92% | 0.60% | 0.00% | 15.40% | -33.08% |
| Total Other Non-Cash Items | -74.48% | 297.00% | -5.49% | 2.39% | 17.37% |
| Change in Net Operating Assets | 257.66% | 75.07% | -254.17% | 278.13% | -273.18% |
| Cash from Operations | 48.05% | -270.55% | -59.98% | 607.66% | 34.03% |
| Capital Expenditure | -109.31% | 3.39% | 41.42% | 18.98% | -45.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 429.47% | 50.40% | 155.12% | -600.92% | 588.48% |
| Cash from Investing | 532.81% | 83.35% | 125.18% | -462.03% | 29.98% |
| Total Debt Issued | -- | -- | -- | -100.00% | -96.94% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -50.53% | 90.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 39.86% |
| Cash from Financing | -747.12% | -303.65% | 150.94% | -50.53% | -122.10% |
| Foreign Exchange rate Adjustments | 186.01% | -186.80% | 311.94% | -291.03% | 226.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 167.29% | -177.54% | 1,404.84% | 111.90% | -10,263.96% |